Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
SEC Accession No. 0000876661-25-000339
Filing Date
2025-05-15
Accepted
2025-05-15 10:48:30
Documents
2
Effectiveness Date
2025-05-15

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 25-NSE  
1 primary_doc.xml 25-NSE 1070
2 ruleprovisionnotice.htm EX-99.25 751
  Complete submission text file 0000876661-25-000339.txt   3658
Mailing Address 11 WALL STREET NEW YORK NY 10005
Business Address 11 WALL STREET NEW YORK NY 10005 212-656-2060
NEW YORK STOCK EXCHANGE LLC (Filed by) CIK: 0000876661 (see all company filings)

EIN.: 000000000 | State of Incorp.: NY
Type: 25-NSE

Mailing Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG
Business Address 79 NEW OXFORD STREET LONDON X0 WC1A 1DG 011442080475000
GSK plc (Subject) CIK: 0001131399 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 25-NSE | Act: 34 | File No.: 001-15170 | Film No.: 25949911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)